Singapore · Delayed Price · Currency is SGD AsiaMedic Statistics
Total Valuation
AsiaMedic has a market cap or net worth of SGD 22.96 million. The enterprise value is 33.18 million.
| Market Cap | 22.96M |
| Enterprise Value | 33.18M |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AsiaMedic has 1.15 billion shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 1.15B |
| Shares Outstanding | 1.15B |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +4.53% |
| Owned by Insiders (%) | 15.31% |
| Owned by Institutions (%) | n/a |
| Float | 531.26M |
Valuation Ratios
The trailing PE ratio is 11.12.
| PE Ratio | 11.12 |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | 6.06 |
| P/OCF Ratio | 5.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.26, with an EV/FCF ratio of 8.75.
| EV / Earnings | 16.67 |
| EV / Sales | 0.95 |
| EV / EBITDA | 7.26 |
| EV / EBIT | 20.86 |
| EV / FCF | 8.75 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.91.
| Current Ratio | 2.25 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 4.03 |
| Debt / FCF | 4.38 |
| Interest Coverage | 1.33 |
Financial Efficiency
Return on equity (ROE) is 11.69% and return on invested capital (ROIC) is 2.02%.
| Return on Equity (ROE) | 11.69% |
| Return on Assets (ROA) | 1.67% |
| Return on Invested Capital (ROIC) | 2.02% |
| Return on Capital Employed (ROCE) | 3.34% |
| Weighted Average Cost of Capital (WACC) | 4.72% |
| Revenue Per Employee | 892,870 |
| Profits Per Employee | 51,056 |
| Employee Count | 39 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 141.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.86% in the last 52 weeks. The beta is 0.17, so AsiaMedic's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +42.86% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 33.62 |
| Average Volume (20 Days) | 386,140 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AsiaMedic had revenue of SGD 34.82 million and earned 1.99 million in profits. Earnings per share was 0.00.
| Revenue | 34.82M |
| Gross Profit | 9.24M |
| Operating Income | 1.15M |
| Pretax Income | 2.01M |
| Net Income | 1.99M |
| EBITDA | 2.00M |
| EBIT | 1.15M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 8.45 million in cash and 16.61 million in debt, with a net cash position of -8.15 million or -0.01 per share.
| Cash & Cash Equivalents | 8.45M |
| Total Debt | 16.61M |
| Net Cash | -8.15M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 18.28M |
| Book Value Per Share | 0.01 |
| Working Capital | 9.48M |
Cash Flow
In the last 12 months, operating cash flow was 4.37 million and capital expenditures -583,174, giving a free cash flow of 3.79 million.
| Operating Cash Flow | 4.37M |
| Capital Expenditures | -583,174 |
| Depreciation & Amortization | 893,411 |
| Net Borrowing | -2.31M |
| Free Cash Flow | 3.79M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 26.53%, with operating and profit margins of 3.29% and 5.72%.
| Gross Margin | 26.53% |
| Operating Margin | 3.29% |
| Pretax Margin | 5.76% |
| Profit Margin | 5.72% |
| EBITDA Margin | 5.74% |
| EBIT Margin | 3.29% |
| FCF Margin | 10.74% |
Dividends & Yields
AsiaMedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | -0.05% |
| Earnings Yield | 8.67% |
| FCF Yield | 16.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |